Sign in
Taking people in United StatesNo phase

Support After Hospital Discharge for People With Type 2 Diabetes

Tests bedside social needs screening and follow-up navigation for adults with type 2 diabetes.

Key facts

Who runs it
University of Massachusetts, Worcester
Where
Worcester, United StatesSee the site
Trial code
Registry title
Re-Engineered Discharge for Diabetes Care Transitions
Status
Recruiting
People taking part
412 people, planned
Started
8 Jun 2026
Expected to end
30 May 2029
Type of study
Interventional, 2 groups
Treatments tested
  • REDDCAT2 Post-Discharge Navigation
  • Treatment as Usual (TAU)
Record updated
30 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes who are in a University of Massachusetts-affiliated hospital and have at least 1 unmet social need, such as a problem with housing or food.

Age
18 years or older
Sex
All sexes can join
Disease stage
Type 2 diabetes, currently in hospital
Biomarker or test result
Said at least 1 unmet social need in a screening survey

Main reasons for not taking part

  • Pregnancy
  • Discharge to a short or long-term nursing facility or hospital
  • Medical contraindication
  • Cognitive impairment
  • Unable to give informed consent

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • adult aged 18 years or older
  • diagnosed with type 2 diabetes
  • hospitalized at Univ of Massachusetts-affiliated hospital
  • endorsed at least 1 unmet social need via screening survey

Who cannot take part

  • cognitive impairment
  • pregnancy
  • discharge to short or long-term nursing facility or hospital
  • medical contraindication
  • unable to provide informed consent

Where in United States

  • UMASS Memorial Healthcare SystemWorcester, United StatesContact: Suzanne MitchellTaking people

About the trial

What the trial wants to find out

The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.

The 2 groups in the trial

  • ControlOther group

    Treatment as usual (TAU)

    Treatment: Treatment as Usual (TAU)

  • InterventionTreatment being tested

    REDDCAT2 Intervention

    Treatment: REDDCAT2 Post-Discharge Navigation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Re-Engineered Discharge for Diabetes Care Transitions: Screening and Addressing Social Determinants of Health Needs at Hospital Discharge
Plain-language title
Support After Hospital Discharge for People With Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 June 2026